Overview
- 2 FDA inspections are on record.
- 1 inspection produced a Form 483.
- The most recent recorded inspection date is 2024-01-26.
At a glance
Inspections
2
Form 483s
1
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 17 Jan 2024 – 26 Jan 2024 | Biologics | 483 | View 483 → |
| 6 Dec 2021 – 10 Dec 2021 | Biologics | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
26 Jan 2024
21 CFR 211.192
Extent of discrepancy, failure investigations
Cited by Unnee Ranjan, Thai D Truong
Investigators
FDA investigators tied to this site in the record.
Unnee Ranjan1 insp.
Thai D Truong1 insp.
Burnell M Henry1 insp.
Christine Harman1 insp.
Derya C Coursey1 insp.
Andrew W Harmon1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 600.14(c) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Novartis Innovative Technologies Inc.'s 1 Form 483
Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat